Clinical Trials Directory

Trials / Completed

CompletedNCT00187278

Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization

Biventricular Pacing for Atrioventricular Block in Left Ventricular Dysfunction to Prevent Cardiac Desynchronization

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,833 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of the study is to evaluate if patients with a standard indication for permanent ventricular pacing, left ventricular ejection fraction without limit, or any QRS duration will profit from the prevention of ventricular desynchronisation.

Detailed description

The study will be performed as a controlled, single-blind, international, multicenter, prospective, randomized, parallel group design. In order to pragmatically examine the effectiveness of biventricular pacing in patients with an indication for ventricular pacing, the study group with biventricular pacing is compared to a control group with standard pacemakers which only allow univentricular (right ventricular) stimulation, as it has been the standard outside of clinical studies until so far.

Conditions

Interventions

TypeNameDescription
DEVICEBiventricular PacingBiventricular Pacemaker implant
DEVICERV PacingStandard Pacemaker implant

Timeline

Start date
2003-05-01
Primary completion
2014-05-01
Completion
2014-10-01
First posted
2005-09-16
Last updated
2021-01-25
Results posted
2021-01-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00187278. Inclusion in this directory is not an endorsement.